| pubmed-article:16049703 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0078058 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0021755 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0040866 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C1171892 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:16049703 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:16049703 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16049703 | pubmed:dateCreated | 2006-2-23 | lld:pubmed |
| pubmed-article:16049703 | pubmed:abstractText | Intravitreal injection of triamcinolone acetonide (TA) is used for the treatment of diabetic macular edema and other vitreoretinal diseases. Vascular endothelial growth factor (VEGF) plays a key role in regulating vascular permeability associated with macular edema. We investigated the effect of TA on the expression of VEGF mRNA and protein induced by interleukin-1 beta (IL-1b) and hypoxia in cultured rat Müller cells. | lld:pubmed |
| pubmed-article:16049703 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16049703 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16049703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16049703 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16049703 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:16049703 | pubmed:issn | 0721-832X | lld:pubmed |
| pubmed-article:16049703 | pubmed:author | pubmed-author:TanakaToruT | lld:pubmed |
| pubmed-article:16049703 | pubmed:author | pubmed-author:KurabayashiMa... | lld:pubmed |
| pubmed-article:16049703 | pubmed:author | pubmed-author:AkiyamaHideoH | lld:pubmed |
| pubmed-article:16049703 | pubmed:author | pubmed-author:KishiShojiS | lld:pubmed |
| pubmed-article:16049703 | pubmed:author | pubmed-author:HagimuraNorik... | lld:pubmed |
| pubmed-article:16049703 | pubmed:author | pubmed-author:DoiHiroshiH | lld:pubmed |
| pubmed-article:16049703 | pubmed:author | pubmed-author:ItakuraHirota... | lld:pubmed |
| pubmed-article:16049703 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16049703 | pubmed:volume | 244 | lld:pubmed |
| pubmed-article:16049703 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16049703 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16049703 | pubmed:pagination | 226-31 | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:meshHeading | pubmed-meshheading:16049703... | lld:pubmed |
| pubmed-article:16049703 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16049703 | pubmed:articleTitle | Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Müller cells. | lld:pubmed |
| pubmed-article:16049703 | pubmed:affiliation | Department of Ophthalmology, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8511, Japan. itakurah@med.gunma-u.ac.jp | lld:pubmed |
| pubmed-article:16049703 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16049703 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
